Category: Emergency Care
WOMAN-2 Trial
The WOMAN-2 trial investigates Tranexamic Acid (TXA) for the prevention of postpartum bleeding in women with anaemia
DetailsWorld Day of Remembrance for Road Traffic Victims
The researchers call urgent TXA treatment of all trauma victims, ideally at the scene of the crash, could prevent over 100,000 premature deaths each year worldwide.
DetailsEducational | Evidence Tranexamic Acid Saves Lives
This is an informative video showing the history and providing compelling evidence tranexamic acid, or TXA, saves lives.
DetailsHALT-IT Trial Results and News
HALT-IT trial found that TXA does NOT reduce deaths from stomach bleeding but increases the risk of thromboembolic events (deep vein thrombosis or pulmonary embolism)
DetailsWOMAN Trial Results and News
Can we prevent women from dying after childbirth? The WOMAN trial showed that if given within 3 hours, TXA can reduce the risk of death due to bleeding by one third.
DetailsThe CRASH-2 Results and News
Global trial CRASH-2 is now complete and shows new hopes to cut deaths from serious injury – a simple jab of Tranexamic Acid could save up to 100,000 lives a year.
Details